Literature DB >> 1916479

Idiopathic bile acid malabsorption--a review of clinical presentation, diagnosis, and response to treatment.

A J Williams1, M V Merrick, M A Eastwood.   

Abstract

Between 1982 and 1989, the seven day retention of 75SeHCAT was measured in 181 patients with chronic diarrhoea that remained unexplained after full investigation. Altogether 121 of the 181 had a seven day 75SeHCAT retention greater than or equal to 15% and thus had no evidence of abnormal bile acid turnover. Twenty one had a seven day 75SeHCAT retention greater than or equal to 10% but less than 15%. Their clinical features were typical of the irritable bowel syndrome, and none of eight treated with cholestyramine showed symptomatic improvement. Sixteen patients had a seven day retention greater than or equal to 5% and less than 10%, six of whom had improved symptoms after treatment with bile acid chelating agents. The remaining 23 patients had a 75SeHCAT retention of less than 5% at seven days and responded to bile acid chelators. This group had a characteristic illness with intermittent watery diarrhoea, but no constitutional upset. It was not possible to distinguish the patients with bile acid malabsorption exclusively on the basis of the clinical symptoms and investigations, other than 75SeHCAT retention. We conclude that the measurement of 75SeHCAT retention is useful, appropriate, and necessary in patients with unexplained chronic diarrhoea.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1916479      PMCID: PMC1379038          DOI: 10.1136/gut.32.9.1004

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  17 in total

1.  Idiopathic bile acid catharsis.

Authors:  E H Thaysen; L Pedersen
Journal:  Gut       Date:  1976-12       Impact factor: 23.059

Review 2.  The syndrome of ileal disease and the broken enterohepatic circulation: cholerheic enteropathy.

Authors:  A F Hofmann
Journal:  Gastroenterology       Date:  1967-04       Impact factor: 22.682

3.  Idiopathic bile acid diarrhoea reconsidered.

Authors:  E H Thaysen
Journal:  Scand J Gastroenterol       Date:  1985-05       Impact factor: 2.423

4.  New method for the determination of bile acid turnover using 75Se-homocholic acid taurine.

Authors:  H Delhez; J W van den Berg; M van Blankenstein; J H Meerwaldt
Journal:  Eur J Nucl Med       Date:  1982

5.  Factors in the mechanism of diarrhea in bile acid malabsorption: fecal pH--a key determinant.

Authors:  B McJunkin; H Fromm; R P Sarva; P Amin
Journal:  Gastroenterology       Date:  1981-06       Impact factor: 22.682

6.  Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man.

Authors:  H S Mekjian; S F Phillips; A F Hofmann
Journal:  J Clin Invest       Date:  1971-08       Impact factor: 14.808

7.  Se-75-labeled bile acid analogs, new radiopharmaceuticals for investigating the enterohepatic circulation.

Authors:  G S Boyd; M V Merrick; R Monks; I L Thomas
Journal:  J Nucl Med       Date:  1981-08       Impact factor: 10.057

8.  Evaluation of ileal function using 23-selena-25-homotaurocholate, a-gamma-labeled conjugated bile acid. Initial clinical assessment.

Authors:  H Nyhlin; M V Merrick; M A Eastwood; W G Brydon
Journal:  Gastroenterology       Date:  1983-01       Impact factor: 22.682

9.  Use of 23-selena-25-homocholyltaurine to detect bile acid malabsorption in patients with illeal dysfunction or diarrhea.

Authors:  G Sciarretta; G Vicini; G Fagioli; A Verri; A Ginevra; P Malaguti
Journal:  Gastroenterology       Date:  1986-07       Impact factor: 22.682

10.  Is bile acid malabsorption underdiagnosed? An evaluation of accuracy of diagnosis by measurement of SeHCAT retention.

Authors:  M V Merrick; M A Eastwood; M J Ford
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-02
View more
  35 in total

1.  British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome.

Authors:  J Jones; J Boorman; P Cann; A Forbes; J Gomborone; K Heaton; P Hungin; D Kumar; G Libby; R Spiller; N Read; D Silk; P Whorwell
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

2.  Guidelines for the investigation of chronic diarrhoea, 2nd edition.

Authors:  P D Thomas; A Forbes; J Green; P Howdle; R Long; R Playford; M Sheridan; R Stevens; R Valori; J Walters; G M Addison; P Hill; G Brydon
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

3.  Are the definitions for chronic diarrhoea adequate? Evaluation of two different definitions in patients with chronic diarrhoea.

Authors:  Per-Ove Stotzer; Hasse Abrahamsson; Antal Bajor; Anders Kilander; Riadh Sadik; Henrik Sjövall; Magnus Simrén
Journal:  United European Gastroenterol J       Date:  2015-08       Impact factor: 4.623

4.  Managing bile acid diarrhoea.

Authors:  Julian R F Walters; Sanjeev S Pattni
Journal:  Therap Adv Gastroenterol       Date:  2010-11       Impact factor: 4.409

5.  Chronic diarrhoea.

Authors:  R Spiller
Journal:  Gut       Date:  2007-12       Impact factor: 23.059

Review 6.  Advances in understanding of bile acid diarrhea.

Authors:  Michael Camilleri
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2013-11-25       Impact factor: 3.869

7.  Biliary lipid composition in idiopathic bile acid malabsorption.

Authors:  M Fracchia; S Pellegrino; P Secreto; A Pera; G Galatola
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

8.  Bile acid malabsorption in Crohn's disease and indications for its assessment using SeHCAT.

Authors:  H Nyhlin; M V Merrick; M A Eastwood
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

9.  Design and characterization of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile Acid transporter activity.

Authors:  Diana Vivian; Kunrong Cheng; Sandeep Khurana; Su Xu; Valerie Whiterock; Drew Witter; Kimberley A Lentz; Kenneth S Santone; Jean-Pierre Raufman; James E Polli
Journal:  Pharm Res       Date:  2013-01-15       Impact factor: 4.200

10.  Gall-bladder and colonic retention of SeHCAT: a re-evaluation.

Authors:  M V Merrick
Journal:  Eur J Nucl Med       Date:  1994-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.